reagentsrecombin
pa
lf
ef
obtain
list
biolog
made
laboratori
enzym
use
molecular
clone
purchas
new
england
biolab
oligonucleotid
synthes
invitrogen
antihi
horseradish
peroxidas
hrp
conjug
fab
hrp
conjug
fc
agaros
purchas
sigma
nickelagaros
bead
obtain
invitrogen
animalschimpanze
immun
time
interv
recombin
pa
lf
ef
alum
adjuv
eight
week
last
immun
bone
marrow
aspir
iliac
crest
anim
fischer
rat
purchas
tacon
farm
experi
involv
anim
perform
protocol
approv
anim
care
use
committe
nation
institut
allergi
infecti
diseas
nation
institut
health
librari
construct
selectionlymphocyt
bone
marrow
aspir
isol
ficol
gradient
mrna
extract
lymphocyt
use
mrna
purif
kit
amersham
bioscienc
cdna
synthes
use
firststrand
cdna
synthesi
kit
amersham
bioscienc
heavychain
vh
lightchain
gene
amplifi
polymeras
chain
reaction
pcr
cycl
min
min
min
use
mixtur
primer
human
v
gene
describ
elsewher
singlechain
variabl
fragment
scfv
assembl
vh
via
splice
overlap
extens
pcr
gelpurifi
scfv
dna
digest
sfii
clone
vector
also
cut
sfii
recombin
plasmid
transform
escherichia
coli
stratagen
electropor
result
librari
individu
clone
phagemid
product
pan
screen
essenti
report
krebber
et
al
brief
phagemid
rescu
superinfect
helper
phage
vc
stratagen
subject
pan
pa
lf
ef
protein
coat
elisa
well
nonspecif
adsorb
phage
remov
extens
wash
specif
bound
phage
elut
mmoll
triethylamin
neutral
ph
amplifi
round
pan
randomli
chosen
singlephag
scfv
clone
screen
specif
bind
phage
elisa
clone
differenti
bound
specif
antigen
valu
absorb
measur
nm
consid
posit
result
wherea
valu
consid
denot
neg
result
clone
bound
specif
pa
lf
ef
variabl
region
vh
light
vl
gene
sequenc
correspond
amino
acid
sequenc
align
convers
scfv
fab
fulllength
iggto
convert
scfv
fab
follow
primer
design
firststrand
cdna
constant
chain
heavi
chain
constant
region
light
chain
gene
fragment
synthes
total
rna
obtain
human
spleen
cell
bd
bioscienc
amplifi
pcr
perform
use
fab
fab
primer
respect
vh
gene
fragment
amplifi
pcr
perform
use
antipa
scfv
dna
templat
pa
pa
primer
fd
segment
produc
splice
overlap
extens
pcr
vh
use
pa
pa
primer
fd
region
digest
xhoi
noti
region
digest
xbai
saci
digest
dna
fragment
clone
match
restrict
site
fab
convert
fulllength
igg
digest
fd
xhoi
apai
clone
vector
contain
human
heavychain
constant
region
yield
plasmid
ppah
digest
xbai
saci
clone
pcnhlc
vector
yield
plasmid
express
purif
scfv
fab
iggboth
scfv
fab
express
e
coli
brief
bacteria
cultur
yt
yeast
medium
contain
glucos
appropri
antibiot
cultur
dilut
yt
without
glucos
contain
mmoll
incub
h
express
protein
purifi
chromatographi
perform
nickelcharg
affin
resin
invitrogen
fulllength
igg
plasmid
ppah
contain
vh
vl
antianthrax
toxin
compon
cotransfect
cell
transient
express
igg
purifi
affin
chromatographi
perform
fc
agaros
sigma
puriti
antibodi
determin
sdspage
novex
invitrogen
protein
concentr
determin
bicinchonin
assay
bca
pierc
biotechnolog
elisa
perform
purifi
human
igg
jackson
immunoresearch
refer
standard
elisapa
lf
unrel
protein
bovin
serum
albumin
bsa
thyroglobulin
lysozym
phosphorylas
b
coat
onto
plate
place
protein
carbon
buffer
ph
concentr
well
incub
plate
room
temperatur
overnight
serial
dilut
solubl
scfv
fab
igg
phage
ad
well
plate
incub
h
room
temperatur
plate
wash
secondari
antibodi
conjug
fabhrp
ad
incub
h
room
temperatur
plate
wash
color
develop
ad
tetramethylbenzidin
solut
tmb
sigma
plate
read
optic
densiti
measur
nm
elisa
plate
reader
competit
elisarecombin
pa
concentr
carbon
buffer
ph
coat
onto
well
elisa
plate
well
incub
antipa
fab
differ
concentr
h
room
temperatur
antipa
fab
remov
well
mous
antipa
mab
respect
ad
well
concentr
plate
incub
h
wash
bound
mab
detect
addit
hrpconjug
antibodi
follow
tmb
substrat
bind
pa
calcul
divid
optic
densiti
valu
absenc
optic
densiti
valu
presenc
competit
fab
igg
fab
igg
test
describ
except
hrpconjug
fc
use
secondari
antibodi
affin
measurementsurfac
plasmon
reson
spr
biosensor
experi
conduct
use
biacor
instrument
biacor
short
carboxymethyl
dextran
sensor
surfac
biacor
standard
amin
coupl
describ
detail
elsewher
experi
conduct
configur
first
antibodi
immobil
surfac
kinet
bind
dissoci
pa
record
min
h
respect
pa
concentr
nmoll
elimin
effect
immobilizationinduc
surfacesit
heterogen
mass
transport
limit
determin
bind
constant
kinet
trace
global
fit
model
continu
ligand
distribut
combin
approxim
mass
transport
second
conduct
solut
competit
experi
differ
concentr
solubl
fab
preincub
pa
h
concentr
unbound
pa
determin
initi
slope
surfac
bind
note
mixtur
pass
antibodyfunction
surfac
standard
competit
isotherm
use
analysi
epitop
mappinga
seri
pa
fragment
differ
size
amplifi
paencod
vector
mean
pcr
describ
elsewher
insert
pgemt
vector
promega
pa
peptid
label
amersham
bioscienc
prepar
tnt
vitro
transcriptiontransl
system
promega
radioimmunoprecipit
assay
perform
essenti
describ
elsewher
brief
mixtur
peptid
antipa
incub
overnight
immun
complex
collect
protein
agaros
bead
amersham
bioscienc
precipit
complex
wash
subject
sdspage
pa
peptid
detect
expos
dri
gel
xray
film
pa
bind
cell
grown
plate
confluenc
ten
microlit
pa
mix
neutral
antibodi
molar
ratio
pa
mab
final
volum
incub
min
min
pb
mix
pa
control
sampl
mixtur
ad
cell
incub
min
medium
remov
cell
wash
time
icecold
pb
follow
lysi
radioimmunoprecipit
assay
buffer
nonidet
sodium
deoxychol
sd
pb
plu
edtafre
complet
proteas
inhibitor
cocktail
roch
appli
scienc
equal
amount
protein
measur
bca
pierc
biotechnolog
load
onto
sdspage
gel
western
blot
analysi
perform
use
antipa
polyclon
antibodi
dilut
develop
laboratori
bacteri
toxin
therapeut
section
nation
institut
allergi
infecti
diseas
hrpconjug
goat
igg
secondari
antibodi
dilut
santa
cruz
biotech
vitro
neutral
assayan
establish
assay
use
determin
vitro
neutral
activ
antibodi
result
plot
effect
concentr
neutral
calcul
use
prism
softwar
graphpad
softwar
vivo
neutral
assaygroup
fischer
rat
sex
femal
bodi
weight
g
inject
via
tail
vein
pb
mixtur
antibodi
palf
lethal
toxin
lt
differ
molar
ratio
antibodi
lt
prepar
steril
pb
inject
volum
rat
observ
continu
first
h
observ
h
h
twicedaili
check
occur
week
rat
monitor
sign
malais
death
rat
pretreat
antibodi
inject
intraven
pb
antibodi
min
h
week
intraven
inject
palf
isol
antipa
antilf
clonesrecombin
protein
use
antigen
select
antibodi
scfv
librari
deriv
immun
chimpanze
round
select
pa
lf
ef
total
phagemid
clone
screen
specif
bind
use
elisa
detect
clone
bound
specif
ef
protein
nineti
percent
clone
recogn
pa
lf
protein
bsa
control
protein
four
uniqu
antipa
uniqu
antilf
scfv
phagemid
clone
identifi
sequenc
analysi
figur
two
clone
similar
sequenc
vh
region
figur
differ
amino
acid
locat
within
primer
region
amino
acid
sequenc
clone
differ
greatli
expect
greatest
diverg
sequenc
length
note
cdr
region
extens
homolog
chimpanze
human
immunoglobulin
similar
search
known
human
immunoglobulin
gene
vbase
databas
conduct
famili
vh
ii
famili
preferenti
use
antianthrax
antibodi
tabl
expect
clone
deriv
vh
germlin
gene
scfv
express
e
coli
purifi
affin
chromatographi
test
bind
activ
specif
elisa
clone
bound
strongli
pa
antigen
clone
bound
strongli
lf
antigen
figur
none
clone
bound
bsa
thyroglobulin
phosphorylas
b
lysozym
data
shown
vitro
neutral
activ
affin
effect
anthrax
toxin
strongli
inhibit
scfv
scfv
data
shown
latter
scfv
undergo
studi
scfv
fragment
limit
use
passiv
immunotherapi
monoval
fragment
rapidli
clear
blood
case
bival
fulllength
immunoglobulin
effect
correspond
scfv
avid
effect
effector
function
prolong
halflif
blood
therefor
scfv
convert
bival
whole
compar
neutral
activ
cellbas
vitro
assay
wellcharacter
mous
antipa
use
comparison
control
neutral
complet
igg
better
neutral
scfv
data
shown
higher
higher
mous
antipa
figur
equilibrium
dissoci
constant
kd
respect
determin
biacor
analysi
antibodi
display
high
affin
kd
moll
respect
compar
kd
moll
present
studi
tabl
affin
compar
favor
report
human
antipa
mab
tabl
highest
record
affin
anthrax
pa
character
neutral
epitop
mechan
neutralizationcompetit
elisa
result
indic
may
recogn
epitop
compet
bind
pa
data
shown
complementaritydetermin
region
vh
chain
ident
therefor
use
map
neutral
epitop
elisa
competit
also
observ
figur
bind
site
respons
bind
cellular
receptor
wherea
compet
bind
distinct
bind
site
bind
site
map
radioimmunoprecipit
assay
smallest
peptid
react
antibodi
contain
aa
correspond
aa
cterminu
pa
figur
result
indic
bound
conform
epitop
encompass
almost
entir
domain
pa
domain
pa
respons
cellular
receptor
bind
result
suggest
neutral
toxin
block
bind
pa
cellular
receptor
conclus
confirm
bind
assay
use
western
blot
analysi
show
prevent
bind
pa
cell
figur
affin
kd
bind
pa
receptor
moll
moll
therefor
affin
antibodi
bind
pa
higher
affin
pa
cellular
receptor
vivo
anim
protect
affin
antipa
strongli
correl
neutral
activ
reason
assum
antipa
potent
neutral
antibodi
report
antipa
mab
one
remark
featur
antibodi
slow
dissoci
rate
may
provid
signific
physiolog
advantag
toxin
neutral
vivo
evalu
neutral
pa
vivo
measur
protect
anthrax
toxin
challeng
fischer
rat
model
way
first
mab
toxin
mix
differ
molar
ratio
mixtur
inject
rat
observ
morbid
death
inject
lt
pa
lf
alon
kill
rat
within
min
tabl
antibodi
confer
protect
low
concentr
addit
antibodi
molar
ratio
ab
pa
lowest
concentr
antibodi
test
complet
protect
rat
anthrax
toxin
challeng
comparison
mous
antibodi
protect
rat
ratio
probabl
reflect
differ
affin
second
stringent
test
mab
inject
min
h
week
inject
lt
pa
lf
investig
durat
antibodi
protect
singl
administr
antibodi
molar
ratio
ab
pa
protect
rat
challeng
toxin
min
h
week
later
tabl
lower
dose
antibodi
still
protect
rat
challeng
min
h
later
challeng
week
later
tabl
identifi
chimpanze
mab
bind
pa
high
affin
antibodi
neutral
cytotox
anthrax
toxin
picomolar
rang
vitro
effici
protect
anim
anthrax
toxin
challeng
vivo
like
block
bind
cell
receptor
neutral
mab
highest
affin
human
antibodi
pa
report
thu
far
antibodi
affin
shown
correl
well
efficaci
neutral
epitop
recogn
mab
map
region
pa
compris
aa
far
neutral
epitop
pa
propos
site
bind
cellular
receptor
site
bind
lf
site
heptam
format
howev
locat
put
epitop
precis
defin
exampl
epitop
recogn
murin
mab
suggest
basi
differenti
bind
differ
pa
fragment
gener
ctermin
delet
ntermin
delet
pa
fragment
test
epitop
map
could
incomplet
previou
observ
pa
fragment
correspond
aa
compet
pa
bind
cell
receptor
suggest
region
aa
aa
suffici
gener
receptor
recognit
site
residu
domain
pa
critic
bind
cellular
receptor
antipa
mab
determin
alaninescan
mutat
anthrax
whether
result
natur
bioterroristassoci
exposur
constant
threat
human
health
although
product
effici
anthrax
vaccin
ultim
goal
benefit
vaccin
expect
larg
proport
popul
risk
immun
low
incid
anthrax
suggest
largescal
vaccin
may
effici
mean
control
diseas
contrast
passiv
administr
neutral
human
chimpanze
mab
subject
risk
anthrax
expos
anthrax
could
provid
immedi
efficaci
emerg
prophylaxi
treatment
anthrax
find
support
recent
studi
indic
passiv
immun
affinityimprov
human
murin
mab
pa
could
effici
protect
rabbit
challeng
aerosol
bacillu
anthraci
spore
howev
human
murin
mab
may
retain
antigen
compon
origin
murin
sequenc
may
elicit
antibodi
mab
human
human
chimpanzeederiv
mab
would
expect
problem
sequenc
chimpanze
immunoglobulin
gene
virtual
ident
human
furthermor
one
would
expect
antipa
chimpanze
mab
provid
better
protect
mab
higher
affin
kd
lower
vitro
neutral
experi
